Fig. 2: PD-L1 expression on tumor VECs signed poorer prognosis of NPC patients. | Cell Death & Disease

Fig. 2: PD-L1 expression on tumor VECs signed poorer prognosis of NPC patients.

From: Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-κB and STAT3 signaling pathways in nasopharyngeal carcinoma

Fig. 2

A, B Kaplan–Meier survival curves of OS (A) and PFS (B) of patients with NPC exhibiting negative (red) or positive (blue) tumor VEC-PD-L1 (TEC-PD-L1). n = 180, Log-rank test. C, E Kaplan–Meier survival curves of OS (C) and PFS (E) of patients with NPC exhibiting N0-1 (red) or N2-3 (blue). n = 180, Log-rank test. D, F Kaplan–Meier survival curves of OS (D) and PFS (F) of patients with NPC exhibiting EBV-DNA < 2000 (red) or EBV-DNA > = 2000 (blue). n = 180, Log-rank test. G, H Kaplan–Meier survival curves of OS (G) and PFS (H) of patients with NPC exhibiting negative (red) or positive (blue) tumor cell-PD-L1 (TC-PD-L1). n = 180, Log-rank test. I, J ROC curves of TEC-PD-L1 (red), TC-PD-L1 (blue), and Double (black) predicting OS (I) and PFS (J) of NPC patients. n = 180, Log-rank test.

Back to article page